Conversation with The Cancer Letter Do African Americans, others at high risk benefit from starting PSA screening early? May 11, 2018Vol.44 No.19By Paul Goldberg
PSA test gets a better grade from USPSTF—it’s a “C” Uncertainty lingers about high-risk groups May 11, 2018Vol.44 No.19By Paul Goldberg
Drugs & Targets Rucaparib approved for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer April 13, 2018Vol.44 No.15
Drugs & Targets FDA finalizes guidances to accelerate development of Next Gen sequencing April 13, 2018Vol.44 No.15
Drugs & Targets MD Anderson, Nanobiotix to collaborate on preclinical research combining NBTXR3, nivolumab April 13, 2018Vol.44 No.15
Clinical Roundup NCI study revises molecular classification for most common type of lymphoma April 13, 2018Vol.44 No.15
Clinical Roundup Updated ASTRO guideline for lung radiation recommends concurrent chemotherapy for some stage III patients April 13, 2018Vol.44 No.15
